Bio-Rad Laboratories BIO
NYSE BIO
$382.40 +3.37 (+0.89%)
As of: Sep 17, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Revenue (QoQ) (2009 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Revenue (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.95%
Mar 31, 2026 -14.58%
Dec 31, 2025 6.16%
Sep 30, 2025 0.21%
Jun 30, 2025 11.31%
Mar 31, 2025 -12.30%
Dec 31, 2024 2.74%
Sep 30, 2024 1.75%
Jun 30, 2024 4.54%
Mar 31, 2024 -10.33%
Dec 31, 2023 7.77%
Sep 30, 2023 -7.19%
Jun 30, 2023 0.64%
Mar 31, 2023 -7.33%
Dec 31, 2022 7.27%
Sep 30, 2022 -1.49%
Jun 30, 2022 -1.29%
Mar 31, 2022 -4.46%
Dec 31, 2021 -1.90%
Sep 30, 2021 4.34%